Novozymes A/S (NVZMY) Stock Forecast & Price Target

NVZMY Forecast - Frequently Asked Questions

Should I buy or sell Novozymes A/S stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novozymes A/S in the last twelve months. There is currently 1 sell rating and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NVZMY shares.

Does Novozymes A/S's stock price have much downside?

According to analysts, Novozymes A/S's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Has Novozymes A/S been upgraded or downgraded by Wall Street analysts recently?

Over the previous 90 days, Novozymes A/S's stock had 2 upgrades and 1 downgrade by analysts.

What analysts cover Novozymes A/S?

Novozymes A/S has been rated by research analysts at Barclays, Berenberg Bank, and Citigroup in the past 90 days.

Do Wall Street analysts like Novozymes A/S more than its competitors?

Analysts like Novozymes A/S more than other "basic materials" companies. The consensus rating for Novozymes A/S is Buy while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how NVZMY compares to other companies.